Providing market intelligence for more than 35 years

In The News

Google share price: Company expands Chromecast technology to target home audio

Google first tested the potential of its streaming media technology with Chromecast, a $35 dongle that can be plugged into a television set to enable people to access digital video services such as YouTube or Netflix. Chromecast was introduced in 2013 and has become a huge success for the online search company. According to Parks Associates the device has emerged as the number two media-streaming device in the US, capturing 20 percent of sales to American homes with broadband access during the first three quarters of last year.

In yesterday’s trading Google shares fell 1.9 percent to $519.46, leaving the company with a market capitalisation of $358.23 billion. The current consensus estimate suggests that investors should buy equity in the company.

From the article "Google share price: Company expands Chromecast technology to target home audio" by Farquar McIntosh.

Previously In The News

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

TV Everywhere Usage Grows

A recent article in Multichannel News provided new findings from Parks Associates showing that 40 percent of U.S. pay TV subscribers used TV Everywhere options in 2015, up from 22 percent in 2013. "TV...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...